AutoGenomics, Inc. Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	29
ISBN Number	not applicable
Product Code	GMD04775

Price

£490.00
approximately: $749 | €546

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a AutoGenomics, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Financial Performance
2.3 Industry Outlook In Vitro Diagnostics
3 Major Products and Services
3.1 Overview
4 Competitors
5 Key Employees
6 Locations And Subsidiaries
6.1 Head Office
7 Recent Developments
7.1 Product News
- 7.1.1 Jan 24, 2008: AutoGenomics Receives FDA Clearance For Its INFINITI Warfarin Assay
7.2 Product Approvals
- 7.2.1 Jan 24, 2008: AutoGenomics Receives FDA Clearance For Its INFINITI Warfarin Assay
8 AutoGenomics, Inc. Pipeline Products
8.1 AutoGenomics, Inc. Product Pipeline Analysis
- 8.1.1 AutoGenomics, Inc. Pipeline Products By Equipment Type
- 8.1.2 AutoGenomics, Inc. Pipeline Products By Development Stage
- 8.1.3 AutoGenomics, Inc. Pipeline Products By Therapy Area
8.2 INFINITI NAT2 Assay
- 8.2.1 Product Description
- 8.2.2 Product Status
8.3 INFINITI CYP450 2D6 Assay
- 8.3.1 Product Description
- 8.3.2 Product Status
8.4 INFINITI HPV-QUAD Assay
- 8.4.1 Product Description
- 8.4.2 Product Status
8.5 INFINITI HPV Genotyping Panel
- 8.5.1 Product Description
- 8.5.2 Product Status
8.6 INFINITI CYP450 3A5 Assay
- 8.6.1 Product Description
- 8.6.2 Product Status
8.7 INFINITI MDR1 Assay
- 8.7.1 Product Description
- 8.7.2 Product Status
8.8 INFINITI CYP450 3A4 Assay
- 8.8.1 Product Description
- 8.8.2 Product Status
8.9 INFINITI CYP450 2C19 Assay
- 8.9.1 Product Description
- 8.9.2 Product Status
8.10 The INFINITI MTHFR
- 8.10.1 Product Description
- 8.10.2 Product Status
8.11 The INFINITI CFTR31 Assay
- 8.11.1 Product Description
- 8.11.2 Product Status
8.12 INFINITI UGT1A1 Assay
- 8.12.1 Product Description
- 8.12.2 Product Status
8.13 INFINITI Ashkenazi Jewish Panel
- 8.13.1 Product Description
- 8.13.2 Product Status
8.14 INFINITI System Assay Respiratory Viral Panel
- 8.14.1 Product Description
- 8.14.2 Product Status
8.15 INFINITI MTBDR Assay
- 8.15.1 Product Description
- 8.15.2 Product Status
8.16 INFINITI CHEK2 Assay
- 8.16.1 Product Description
- 8.16.2 Product Status
9 Appendix
9.1 Methodology
- 9.1.1 Coverage
- 9.1.2 Secondary Research
- 9.1.3 Primary Research
- 9.1.4 Expert Panel Validation
9.2 Contact Us
9.3 About Global Markets Direct
9.4 Disclaimer
1 List of Tables
Table 1: AutoGenomics, Inc.,Key Facts
Table 2: AutoGenomics, Inc., Key Employees,
Table 3: AutoGenomics, Inc. Pipeline Products by Equipment Type
Table 4: AutoGenomics, Inc. Pipeline Products By Development Stage
Table 5: AutoGenomics, Inc. Pipeline Products By Therapy Area
1.2 List of Figures
Figure 1: AutoGenomics, Inc. Pipeline Products By Development Stage
Figure 2: Global Markets Direct Methodology